Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10904420 | 0.79 | GAA (0.47) | CYP3A4SMN1; SMN2GAAALDH1A1TSHR | |
| SCHEMBL9731132 | 0.75 | KCNN4 (0.47) | CYP1A2CYP3A4CYP2C19SMN1; SMN2GAA | |
| SCHEMBL15921015 | 0.72 | SMN1; SMN2 (0.42) | SMN1; SMN2GAAALDH1A1TSHRKMT2A | |
| SCHEMBL15921161 | 0.72 | SMN1; SMN2 (0.42) | CYP2C19SMN1; SMN2GAAALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL11387397 | 0.70 | NR4A1 (0.57) | CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL15933329 | 0.70 | SMN1; SMN2 (0.43) | SMN1; SMN2GAAALDH1A1KMT2AMEN1 | |
| SCHEMBL15921413 | 0.67 | SMN1; SMN2 (0.48) | SMN1; SMN2GAAALDH1A1TSHRKMT2A | |
| SCHEMBL22471127 | 0.67 | NR4A1 (0.62) | CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL27949777 | 0.67 | ATP4A (0.48) | CYP1A2CYP3A4CYP2C19KMT2ALMNA | |
| SCHEMBL3433008 | 0.66 | GAA (0.60) | CYP2C19GAAALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6200991-B1 | M3-MUSCARINIC OR 5-HT SEROTONINERGIC RECEPTOR ANTAGONISTS; IRRITABLE BOWEL SYNDROME, INCONTINENCE, COGNITION ACTIVATORS; RESPIRATORY SYSTEM DISORDERS | SANOFI-SYNTHELABO (FR) | 2001-03-13 | — | — | US | disclosed |
| EP-1032569-A1 | IMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF | SANOFI-SYNTHELABO (FR) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999025710-A1 | IMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF | SANOFI-SYNTHELABO (FR) | 1999-05-27 | — | — | WO | disclosed |
| WO-1996003387-A1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |